ANAB
AnaptysBio, Inc.
NASDAQ · USHealthcareBiotechnology
$50.97-12.12%
Price as of Jul 20, 2026
ANAB earnings
AnaptysBio, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 5, 2026in NaN days
EPS est $-0.13 · Revenue est $17M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -48.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-0.32 | $-1.84 | -475.0% | $26M | +35.5% |
| Mar 3, 2026 | $0.89 | $1.58 | +77.5% | $108M | +24.3% |
| Nov 4, 2025 | $-1.06 | $0.52 | +149.1% | $76M | -12.4% |
| Feb 27, 2025 | $-1.61 | $-0.72 | +55.3% | $43M | +453.9% |
| May 9, 2024 | $-1.54 | $-1.64 | -6.5% | $7M | +80.8% |
| Mar 11, 2024 | $-1.74 | $-1.59 | +8.6% | $9M | +343.6% |
| Nov 2, 2023 | $-1.72 | $-1.41 | +18.0% | $3M | +44.3% |
| May 11, 2023 | $-1.04 | $-1.58 | -51.9% | $1M | -61.5% |
| Mar 1, 2023 | $-0.92 | $-0.93 | -1.1% | $7M | +17.7% |
| May 4, 2022 | $-0.87 | $-1.31 | -50.6% | $970000 | -80.8% |
| Mar 7, 2022 | $2.28 | $-1.13 | -149.6% | $1M | +3.6% |
| Nov 4, 2021 | $-0.74 | $-0.24 | +67.6% | $21M | +174.9% |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-05.